Thanks for your question. We will answer you soon.
Treatment with Etanercept (EnbrelŪ) for Rheumatoid Arthritis (RA)
Yousaf Ali, MD, FACR
Mount Sinai School of Medicine, New York, NY

Date Added: 05/14/13

Etanercept or Enbrel is a biologic drug that was developed between 1999 and 2000, around that area about 13 years ago. It's a drug that specifically, it's a P-75 receptor antagonist so it blocks the molecule that TNF, Tumor Necrosis Factor binds to. TNF is a molecule that promotes inflammation. This...
---------------------------------------------------------- ----------------------------------------------------------
Dr. Yousaf Ali, MD, is a graduate of the Royal Free Hospital School of Medicine in London. After 2 years of postgraduate training in the UK, Dr. Ali moved to the US and completed Internal Medicine training at OHSU in Portland, Oregon. He then trained in Rheumatology at Yale University and is board certified in both Rheumatology and Internal Medicine. He is the current Interim Chief of Rheumatology. Dr. Ali was in practice in Providence, Rhode Island for 9 years where he was an Assistant Clinical Professor of Medicine at Brown University. He received many awards including the prestigious Beckwith Family award for outstanding teaching. He has published many articles, book chapters, and has lectured widely on Rheumatoid arthritis, Osteoporosis, Gout, SLE, Osteoarthritis and the development and study of Novel Biologic therapeutics.
Have Additional Questions About RA?
Get answers from our physicians
Thank you for your question, and for helping us make this RA Community more robust and helpful to patients like yourself. We'll be in touch soon.